Relmada Therapeutics updates corporate presentation; no material new information disclosed

RELMADA THERAPEUTICS, INC.

Company filed updated corporate presentation as Exhibit 99.1 on August 10, 2023.
Presentation titled 'Targeting Major Advances in the Treatment of CNS Disorders'.
Filing does not include specific new financial results, guidance, or milestones.
No material changes to corporate strategy or pipeline disclosed in the filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.